Related Experiment Videos

A case of giant cell myocarditis and malignant thymoma: a postmortem diagnosis by needle biopsy

C M Kilgallen1, E Jackson, M Bankoff

  • 1Department of Pathology, New England Medical Center, Boston, Massachusetts 02111, USA.

Clinical Cardiology
|February 25, 1998
PubMed

Insights

Fulminant giant cell myocarditis, a rare heart inflammation, was diagnosed in a patient with malignant thymoma. A novel needle biopsy technique successfully obtained diagnostic cardiac tissue for confirmation.

Area of Science:

  • Cardiology
  • Oncology
  • Pathology

Background:

  • Giant cell myocarditis is a rare and aggressive form of myocardial inflammation.
  • Malignant thymoma is a tumor of the thymus gland, often associated with paraneoplastic syndromes.
  • Myocarditis can present with diverse clinical manifestations, posing diagnostic challenges.

Observation:

  • A 46-year-old woman presented with symptoms suggestive of fulminant myocarditis.
  • The patient had a concurrently diagnosed malignant thymoma.
  • Diagnosis of giant cell myocarditis was confirmed postmortem, necessitating a specialized biopsy technique.

Findings:

  • A novel percutaneous needle biopsy technique using a bone marrow trephine needle was successfully employed to obtain adequate myocardial tissue.
  • High-quality tissue preservation was achieved, allowing for detailed immunohistochemical analysis.
  • Immunohistochemistry confirmed the giant cells in the myocardium were of macrophage derivation.

Implications:

  • This case highlights the association between malignant thymoma and fulminant giant cell myocarditis.
  • The developed needle biopsy technique offers a minimally invasive method for diagnosing cardiac conditions when larger biopsies are not feasible.
  • Understanding the macrophage origin of giant cells aids in elucidating the pathogenesis of this rare condition.

Related Concept Videos